Bronchiectasis Treatment Program

National Jewish Health doctors have evaluated and treated bronchiectasis for decades. Currently, National Jewish Health scientists are investigating new treatments for bronchiectasis. They are also pursuing aggressive treatment programs designed to minimize or prevent the occurrence of bronchiectasis.

Bronchiectasis makes people more susceptible to lung infections. Our professionals in the specialize in the management of patients with bronchiectasis and the infections associated with the condition.

 

Treatment for Primary Ciliary Dyskinesia (PCD)

National Jewish Health is committed to a team effort with respiratory therapist (RT), nurses, and physicians working closely together to coordinate a comprehensive individualized treatment plan for each patient. We also believe in a close working relationship with The Children’s Hospital in Denver where fellow PCD experts practice and engage in research. Together we as a community strive to provide exception care to those facing the disease of PCD and its associated conditions.
 

Team

  • Physicians: Hara Levy, Jane Gross, David Ferraro, Steven Lommatzsch
  • RNs and MA: Melonie Arthur, Josh McFerrin, Mari Zapata
  • Respiratory Therapist: Cheryl Torres and Whitney Johnson

 

Related Programs


Doctors

Clinical Trials

Tuberculosis Testing for Healthy Adults

Researchers are developing a new test to see if healthy adults could have latent, or inactive, tuberculosis.

Learn More

Reasons to Choose National Jewish Health

  • The leading respiratory hospital in the nation and the only one devoted fully to the treatment of respiratory and related illnesses
  • Ranked as one of the top two hospitals in pulmonology every year since U.S. News & World Report included this category in its annual “Best Hospitals” survey
  • Ranked in the top 1 percent of hospitals in the nation by HCAHPS
  • Physicians consistently recognized among the best in the nation by multiple services, including Best Doctors in America and Castle Connolly
  • Among the top 6 percent of organizations funded for research by the NIH, providing patients access to more than 300 active clinical trials
  • 121-year history of focus on care, research and education serving thousands of patients with lung, heart, immune and related disorders